Lisa Taylor is a patient representative on NRG Oncology’s Data Monitoring Committee and a previous member of the Developmental Therapeutics and Uterine Corpus Committees. She also served on the Uterine Task Force of the National Cancer Institute’s Gynecological Cancer Steering Committee and was a member of the Data Safety Monitoring Board for a phase II therapeutic vaccine trial in cervical intraepithelial neoplasia. She taught as faculty at the ASCO/AACR “Methods in Clinical Cancer Research” Workshop from 2011 to 2015.

Taylor holds a bachelor’s degree in human biology from Stanford University and a master’s in business administration from Harvard University. Her involvement in advocacy is driven by personal loss of family members and friends and her own experience with thyroid cancer. She is president and founder of Packers Falls Group, Inc., a small consultancy focusing on commercial development for both early-stage and large biopharmaceutical companies. This is her third year as a panel member at AAADV.